Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult … (NCT06644664) | Clinical Trial Compass
CompletedNot Applicable
Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers
United States292 participantsStarted 2024-09-24
Plain-language summary
This clinical trial evaluates the effect of message framing on smoking behaviors among lesbian, gay, bisexual, transgender, queer (LGBTQ+) young adults who use nicotine and/or tobacco. Tobacco regulation has contributed to a steady decline in tobacco products designed to be smoked (combustible), but there has been an increase in the use of new tobacco products, such as electronic nicotine delivery systems (ENDS). The use of more than one tobacco product (polytobacco) is high in LGBTQ+ populations. Both LGBTQ+ people and people who engage in polytobacco use are less likely to view tobacco as harmful, which may reinforce tobacco use. Message framing includes culturally targeted messages to communicate the absolute risks (AR) and relative risks (RR) of polytobacco use. Using message framing may increase quit rates or change smoking behaviors in LGBTQ+ young adults who use nicotine and/or tobacco products.
Who can participate
Age range
18 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18-35 years old
* Self-identify as LGBTQ+
* Able to speak English fluently
* An ever user of ENDS and combustible tobacco who currently use ENDS, combustible cigarettes, or both ENDS and combustible cigarettes
* Currently reside in the United States (US)
* Have a mobile phone through a U.S. carrier with MMS messaging and can send and receive text messages for study participation
* Access to the internet with Zoom capabilities
Exclusion Criteria:
* Have a landline or Voice Over Internet Protocol (VOIP) phone number
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial used text-based anti-tobacco messages — MMS messages — to try to change smoking behavior in young adults who use multiple tobacco products. Could an approach like this be useful as part of my own quit attempt, or does my doctor think other cessation methods would work better for my situation?
2The trial looked at whether these anti-tobacco messages were acceptable and feasible for diverse groups of young adult smokers — what does my doctor think about whether I fit the kind of person this research was designed around, and whether those findings would apply to me?
3Since this trial is listed as completed and was in a non-standard phase focused on testing messaging rather than a drug or medical procedure, does my doctor know if any results have been published, and what they showed about whether the messages actually helped people quit all tobacco products?
4This study focused on 'polytobacco' use — meaning people who use more than one type of tobacco product — so if that describes me, should I be talking to my doctor about a cessation plan that specifically addresses quitting multiple products at once rather than just one?
5Are there currently available smoking cessation programs or treatments my doctor would recommend that already use some of the message-framing strategies this trial was studying, so I don't have to wait for research findings to benefit from that approach?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Total tobacco cessation
Timeframe: At 12 weeks post-baseline
2
Acceptability of multimedia messaging service (MMS) anti-polytobacco messages
Timeframe: At 6-week post-enrollment
3
Feasibility of MMS anti-polytobacco messages
Timeframe: At 6-weeks post-enrollment
Trial details
NCT IDNCT06644664
SponsorOhio State University Comprehensive Cancer Center